The Stop TB Partnership’s Global Drug Facility (GDF) facilitates global access to quality-assured, affordable TB diagnostics and treatments.
Since its creation in 2001, GDF has grown into a one-stop bundled procurement and supply mechanism providing a unique package of services that combine strategic procurement of TB products and coordination of market activities, with technical assistance and capacity-building for TB programmes. This unique approach has made GDF the largest global provider of quality-assured TB products to the public sector and was recognized by world leaders in the United Nations Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis, which encouraged all nations to utilize GDF service.
“We, Heads of State and Government and representatives of States and Governments [...] recognize the role played by the Stop TB Partnership/Global Drug Facility, which has, since its creation in 2001, increased access to high quality and affordable TB treatment and diagnostics to populations in need, and is open as an option to be considered for use by all nations, and therefore encourage all nations to use the Stop TB Partnership/Global Drug Facility.”
United Nations General Assembley, October 10th, 2018 A/RES/73/3
